We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$273B
AUM Growth
+$20.9B
Cap. Flow
+$2.91B
Cap. Flow %
1.06%
Top 10 Hldgs %
16.06%
Holding
3,565
New
168
Increased
2,233
Reduced
898
Closed
80

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$892M
2
MRK icon
Merck
MRK
+$858M
3
AMGN icon
Amgen
AMGN
+$857M
4
HD icon
Home Depot
HD
+$837M
5
CSCO icon
Cisco
CSCO
+$781M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$776M
2
UPS icon
United Parcel Service
UPS
+$615M
3
QCOM icon
Qualcomm
QCOM
+$587M
4
BABA icon
Alibaba
BABA
+$555M
5
ETN icon
Eaton
ETN
+$508M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 12.96%
3 Healthcare 11.88%
4 Consumer Discretionary 11.22%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMI
3351
DELISTED
Chembio diagnostics, Inc.
CEMI
$148K ﹤0.01%
41,983
-7,487
-15% -$41.7K
CARM
3352
DELISTED
Carisma Therapeutics
CARM
$147K ﹤0.01%
2,818
HMPT
3353
DELISTED
Home Point Capital, Inc Common Stock
HMPT
$146K ﹤0.01%
+15,618
New +$176K
FNHC
3354
DELISTED
FedNat Holding Company Common Stock
FNHC
$142K ﹤0.01%
30,662
AQB icon
3355
AquaBounty Technologies
AQB
$4.66M
$141K ﹤0.01%
+1,050
New +$181K
LODE icon
3356
Comstock
LODE
$208M
$138K ﹤0.01%
+3,005
New +$97.8K
SCTL
3357
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$137K ﹤0.01%
48,985
ATXS
3358
DELISTED
Astria Therapeutics
ATXS
$132K ﹤0.01%
7,602
-1,206
-14% -$21.8K
ONCT
3359
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$132K ﹤0.01%
+793
New +$105K
CVGI icon
3360
Commercial Vehicle Group
CVGI
$154M
$130K ﹤0.01%
13,417
LABP
3361
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$130K ﹤0.01%
+1,344
New +$175K
BSBK icon
3362
Bogota Financial
BSBK
$116M
$128K ﹤0.01%
12,447
VERO
3363
DELISTED
Venus Concept
VERO
$127K ﹤0.01%
327
+87
+36% +$34.7K
PRTH icon
3364
Priority Technology Holdings
PRTH
$535M
$124K ﹤0.01%
17,854
AMPE
3365
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$124K ﹤0.01%
244
SEEL
3366
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$123K ﹤0.01%
+6
New +$70K
RRD
3367
DELISTED
RR Donnelley & Sons Co.
RRD
$122K ﹤0.01%
29,824
-3,487,463
-99% -$11.1M
UAVS icon
3368
AgEagle Aerial Systems
UAVS
$40.9M
$121K ﹤0.01%
19
-6
-24% -$56.2K
CWBR
3369
DELISTED
CohBar, Inc. Common Stock
CWBR
$119K ﹤0.01%
2,903
SIEB icon
3370
Siebert Financial
SIEB
$66.7M
$118K ﹤0.01%
29,034
+3,363
+13% +$16.2K
TTI icon
3371
TETRA Technologies
TTI
$1.14B
$116K ﹤0.01%
48,014
+14,991
+45% +$32.3K
LCTX icon
3372
Lineage Cell Therapeutics
LCTX
$269M
$114K ﹤0.01%
48,167
-18,013
-27% -$43.3K
PHAS
3373
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$113K ﹤0.01%
32,407
-8,241
-20% -$33.4K
NMRD
3374
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$111K ﹤0.01%
14,458
LNSR icon
3375
LENSAR
LNSR
$61.5M
$107K ﹤0.01%
14,647
-93,186
-86% -$727K

Similar funds

Charles Schwab's Q1 2021 Portfolio in Review

As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
  • Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
  • Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
  • Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
  • Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
  • Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
  • Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.

Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.